Abstract:Background: Mismatch repair deficiency (dMMR) due to germline mutations in DNA repair genes including MLH1, MSH2, MSH6 and PMS2, or somatic aberrant silencing of MLH1, is a well-established feature for Lynch syndrome, a major type of hereditary colorectal cancer (CRC). The purpose of this study is to derive prevalence of germline MMR gene mutations in Chinese population with dMMR CRC. Methods: ColonCore panel is designed for simultaneous detection of microsatellite instabiligy (MSI) status of 22 regions and mutations in 38 CRC-related genes. Whole exons of the 38 genes were covered by the panel. The MSI phenotype detection method was a read-count-distribution-based approach. It utilized the coverage ratio of a specific set of repeat lengths as the main characteristic of each microsatellite locus, and categorized a locus as unstable if the coverage ratio was less than a given threshold. The MSI status of a sample was determined by the percentage of unstable loci in the given sample. Results: Among 1394 postsurgical CRC patients whose MMR status were detected by immunohistochemistry (IHC), 99 patients were dMMR, accounting for 7.1%. The concordance rate was 92.3% between MSI and IHC. Next, we investigated the germline mutation spectrum of dMMR patients. About 26.3% patients harbored pathogenic germline MMR gene mutations, with 13%, 6%, 5% and 2% of patients carrying pathogenic MLH1, MSH2, MSH6 and PMS2 mutations, respectively. Specially, about 30% pathogenic MLH1 mutation occured in splice region. Among patients with pathogenic MMR gene mutations, their first cancer was diagnosed ranging from 22 to 69 years old with median age at diagnosis was 50, and only 57% have a family history of ≥ 1 relative with Lynch syndrome related cancers. Furthermore, 3% harbored pathogenic mutations in other genes. Approximately, 17% of patients harbored MMR gene variants of unknown significance (VUS) and 26% harbored other VUS. The remaining 28% of patients had no pathogenic or VUS mutations from this panel. Conclusions: The prevalence rate of germline pathogenic mutations is 26% in dMMR CRC patients, accounting for 1.8% of all resectable CRC patients. Median age at diagnosis of Lynch syndrome related cancers is 50 years old and nearly 40% Lynch syndrome patients have no family history. Legal entity responsible for the study: Ying Yuan. Funding: Burning Rock Biotech. Disclosure: C. Liu: Burning Rock Biotech. All other authors have declared no conflicts of interest.

Msh2 Deficiency Contributes to Accelerated Apc-Mediated Intestinal Tumorigenesis

Spontaneous Intestinal Carcinomas and Skin Neoplasms in Msh2-deficient Mice.

DNA Mismatch Repair Preferentially Protects Genes from Mutation.

Disruption of the RP-MDM2-p53 pathway accelerates APC loss-induced colorectal tumorigenesis

Spontaneous Intestinal Carcinomas and Skin Neoplasms in / Vfs 7 ? 2-deficient Mice 1

Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation

Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

[Mutational Studies of Adenomatous Polyposis Coli Gene in Carcinomas from Patients with Hereditary Non-Polyposis Colorectal Cancers].

Role of the Mismatch Repair Gene, Msh6, in Suppressing Genome Instability and Radiation-Induced Mutations

Role of nucleotide excision repair deficiency in intestinal tumorigenesis in multiple intestinal neoplasia (Min) mice

The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells

Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice

The Prevalence of Germline Mutations in Chinese Colorectal Cancer Patients with Mismatch Repair Deficiency.

Mlh1 deficiency in normal mouse colon mucosa associates with chromosomally unstable colon cancer

Mouse models of DNA mismatch repair in cancer research

Newly discovered genomic mutation patterns in radiation-induced small intestinal tumors of ApcMin/+ mice

Data from The Transcriptomic Landscape of Mismatch Repair-Deficient Intestinal Stem Cells

Nuclear adenomatous polyposis coli suppresses colitis-associated tumorigenesis in mice

The MutSβ complex is a modulator of p53-driven tumorigenesis through its functions in both DNA double-strand break repair and mismatch repair

Molecular drivers of tumor progression in microsatellite stable APC mutation-negative colorectal cancers

Altered Interactions between the Gut Microbiome and Colonic Mucosa Precede Polyposis in APCMin/+ Mice